Dermatological Issues in a Child with Diabetes Mellitus

  • Pearl C. Kwong


It is now a well-recognized fact that diabetes mellitus (DM) is associated with cutaneous manifestations1-4. Cutaneous manifestations in DM are estimated to occur at a frequency of at least 30% to 70%, but with increasing awareness of the various cutaneous manifestations of DM, it may even approach almost 100%4. The spectrum of skin diseases in DM are numerous and diverse. These conditions can range from benign conditions to life threatening conditions with bad consequences. Some are pathognomonic for DM; yet some are weakly associated with diabetes. Others are a result of the complications or treatment of DM. Sometimes the skin condition may precede the diagnosis of DM, but most often appear after the diagnosis of DM. Regardless of all of these, it is important for the clinician to recognize the cutaneous manifestations of DM so that treatment and /or prevention can be instituted appropriately. This chapter will address the dermatological issues that can present in a child with diabetes. Table 1 is an outline of the major skin disorders associated with DM in children and adolescents.


Cutaneous Manifestation Acanthosis Nigricans Granuloma Annulare Pediatric Diabetes Insulin Allergy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Edidin, D.V. Cutaneous manifestations of diabetes mellitus in children. Pediatr Dermatol 1985; 2, 161–179.PubMedCrossRefGoogle Scholar
  2. 2.
    Jelinek, I.E. Cutaneous manifestations of diabetes mellitus. Int J Derm 1994; 33, 605–617.PubMedCrossRefGoogle Scholar
  3. 3.
    Perez, M.I., and Kohn, S.R. Cutaneous manifestations of diabetes mellitus. J Am Acad Dermatol 1994; 30, 519–529.PubMedCrossRefGoogle Scholar
  4. 4.
    Sibbald, R.G., Landolt, S.J., and Toth, D. Skin and Diabetes. Endocrino Metab Clin North Am 1996; 25, 463–472.CrossRefGoogle Scholar
  5. 5.
    Rosenbloom, A.L., and Frias, J.L. Diabetes, short stature and joint stiffness — a new syndrome. Clin Res 1974; 22, 92A.Google Scholar
  6. 6.
    Starkinan, H., and Brink, S. Limited joint mobility of the hand in type I diabetes mellitus. Diabetes Care 1982; 5, 534–536.CrossRefGoogle Scholar
  7. 7.
    Grgic, A., Rosenbloom, A.L., Weber, F.T., Giordano, B., Malone, J.L, and Shuster, JJ. Joint contracture-common manifestation of childhood diabetes mellitus. J Pediatr 1976; 88, 584–588.PubMedCrossRefGoogle Scholar
  8. 8.
    Seibold, J.R. Digital sclerosis in children with insulin dependent diabetes mellitus. Arthritis Rheum 1982; 25, 1357–1361.PubMedCrossRefGoogle Scholar
  9. 9.
    Heathcote, J.G., Cohen, H., and Noble, J. Dupuytren’s disease and diabetes mellitus. Lancet 1981; 1; 1420.PubMedCrossRefGoogle Scholar
  10. 10.
    Buckingham, B.A., Uitto, J., Sandborg, C., Keens, T., Kaugman, F., and Landing, B. Scleroderma-like syndrome and the non-enzymatic glycosylation of collagen in children with poorly controlled insulin-dependent diabetes (IDDM). Pediatr Res 1981; 15, 626.CrossRefGoogle Scholar
  11. 11.
    Friedman, N.E., Levitsky, L.L., Edidin, D.V., Vitullo, D.A., Lascina, J.J., and Chiemming-Kottip, P. Echocardiographic evidence for impaired myocardial performance in children with type I diabetes mellitus. Am J. Med 1982; 173, 846–850.CrossRefGoogle Scholar
  12. 12.
    Savin, J.A. Bacterial infections in diabetes mellitus. Br J Dermatol 1974; 91, 481–487.PubMedCrossRefGoogle Scholar
  13. 13.
    Lyons, T.J., and Kennedy, L. Non-enzymatic glycosylation of skin collagen in patients with type I (insulin-dependent) diabetes mellitus and limited joint mobility. Diabetologia 1985; 28(2-5).PubMedCrossRefGoogle Scholar
  14. 14.
    Rosenbloom, A.L., Silverstein, J.H., Lezotte, D.C., Richardson, K., and McCallum, M. Limited joint mobility in childhood diabetes mellitus indicates increased risk for microvascular disease. N Engl J Med 1981; 305, 191–194.PubMedCrossRefGoogle Scholar
  15. 15.
    Lieberman, L.A., Rosenbloom, A.L., Riley, W.J., and Silverstein, J.H. Correlated changes in skin thickness and glycosylated hemoglobin with pump administration of insulin. Clin Res 1980; 28, 866A.Google Scholar
  16. 16.
    Muller, S.A., and Winkelmann, R.K. Necrobiosis lipoidica diabeticorum. Results of glucose tolerance tests in nondiabetic patients. JAMA 1961; 119; 139–142.Google Scholar
  17. 17.
    Lowitt, M.H., and Dover, J.S. Necrobiosis lipoidica. J Am Acad Dermatol 1991; 25, 735–748.PubMedCrossRefGoogle Scholar
  18. 18.
    Boulton, A.J.M., Cutfield, R.G., Abouganem, D. et al. Necrobiosis lipoidica diabeticorum: A clinicopathologic study. J Am Acad Dermatol 1988; 18, 530–537.PubMedCrossRefGoogle Scholar
  19. 19.
    Stratham, B., Finlay, A.Y., and Marks, R. A randomized double-blind comparison of aspirin-dipyramidole combination vs placebo in the treatment of necrobiosis lipoidica. Acta Dermatol Venereol 1981; 61; 270–271.Google Scholar
  20. 20.
    Dubin, B J., and Kaplan, E.N. The surgical treatment of necrobiosis lipoidica diabeticorum. Plast Reconstr Surg 1977; 60, 421–427.PubMedGoogle Scholar
  21. 21.
    Huntley, A.C. The cutaneous manifestations of diabetes mellitus. J Am Acad Dermatol 1982; 7, 427–455.PubMedCrossRefGoogle Scholar
  22. 22.
    Boyd, S.G., Innes, S.M., and Campbell, LW. Skin manifestations of diabetes mellitus. Practitioner 1982; 226, 253–264.PubMedGoogle Scholar
  23. 23.
    Binkley, G.W. Dermopathy in diabetes mellitus. Arch Dermatol 1965; 92, 106–107.CrossRefGoogle Scholar
  24. 24.
    Danowski, T.S., Sabeh, G., Sarver, M.E., Shelkrot, J. and Fisher, E.R. Shin spots and diabetes mellitus. Am J Med Sci 1966; 251, 570–575.PubMedCrossRefGoogle Scholar
  25. 25.
    Binkley, G.W., Giraldo, B., and Stoughton, K.B. Diabetic dermopathy — A clinical study. Cutis 1967; 3, 955–958.Google Scholar
  26. 26.
    Fisher, E.R., and Danowski, T.S. Histologic histochemical and electron microscopic features of the shin spots of diabetes mellitus. Am J Clin Path 1968; 50, 547–554.PubMedGoogle Scholar
  27. 27.
    Haim, S., Friedman-Birnbaum, R., Shafir, A. Generalized granuloma annulare:relationshipto diabetes mellitus as revealed in 8 cases. Br J Dermatol 1970; 83, 302–305.PubMedCrossRefGoogle Scholar
  28. 28.
    Dicken, C.H., Carrington, S.G., and Winkelmann, R.K. Generalized granuloma annulare. Arch Dermatol 1969; 99, 556–563.PubMedCrossRefGoogle Scholar
  29. 29.
    Edwards, J.E., Tillman, D.B., Miller, M.E. et al. Infection and diabetes mellitus. West J Med 1979; 130, 515–521.Google Scholar
  30. 30.
    Kimmerly, S.A. Dermatologic manifestations of infections in diabetics. Infect Dis Clin of North Am 1994; 8, 523–532.Google Scholar
  31. 31.
    Moutschen, M.P., Scheen, A.J., and Lefevre, PJ. Impaired immune responses in diabetes mellitus: analysis of the factors and mechanisms involved. Relevance to the increased susceptibility of diabetic patients to specific infections. Diabet Metab 1992; 18, 187–201.Google Scholar
  32. 32.
    Sonck, C.E., and Somersalo, O. The yeast flora of the anogenital region in diabetic girls. Arch Dermatol 1963; 88, 846–852.PubMedCrossRefGoogle Scholar
  33. 33.
    Knight, L., and Fletcher, J. Growth of Candida albicans in saliva: Stimulation by glucose associated with antibiotics, corticosteroids, and diabetes mellitus. J Infect Dis 1971; 123, 371–377.PubMedCrossRefGoogle Scholar
  34. 34.
    Alteras, I, and Saryt, E. Prevalence of pathogenic fungi in the toewebs and toenails of diabetic patients. Mycopathologia 1979; 67, 157–159.PubMedCrossRefGoogle Scholar
  35. 35.
    Ryan-Poirier, K., Eiseman, R.M., Beaty, J.H., Hunt, P.G., Burghen, G.A., and Leggidro, RJ. Post-traumatic cutaneous mucormycosis in diabetes meliitus. Clin Pediatr 1988; 27, 609–612.CrossRefGoogle Scholar
  36. 36.
    Tomford, J.W., Whittlesey, D., Ellner, J.J., Tomashefski, J.F. Invasive primary cutaneous phycomycosis in diabetic leg ulcers. Arch Surg 1980; 115, 770–771.PubMedCrossRefGoogle Scholar
  37. 37.
    Limongelli, W.A., Clark, M.S., Jaglimbene, R., Baden, E., Washington, J.A., and Williams, A.C. Successful treatment of mucocutaneous mucormycosis after dental extraction in a patient with uncontrolled diabetes. J Oral Surg 1975; 33, 705–712.PubMedGoogle Scholar
  38. 38.
    Lipsky, B.A., Pecoraro, R.E., Chen, M.S. et al. Factors affecting staphylococcal colonization among NIDDM outpatients. Diabetes Care 1987; 10, 483–486.PubMedCrossRefGoogle Scholar
  39. 39.
    Menitt, W.T., Bass, J.W., and Brahn, F.W. Malignant external otitis in an adolescent with diabetes. J Pediatr 1980; 96, 872–873.CrossRefGoogle Scholar
  40. 40.
    Joachims, H.Z. Malignant external otitis in children. Arch Otolaryngol 1976; 102, 236–237.PubMedCrossRefGoogle Scholar
  41. 41.
    Haroon, T.S. Diabetes and skin – a review. Scot Med J 1974; 19, 257–267.PubMedGoogle Scholar
  42. 42.
    Montes, L.F., Dobson, H., Dodge, B.G., and Knowles, W.R. Erythrasma and diabetes meliitus. Arch Dermatol 1969; 99, 674–680.PubMedCrossRefGoogle Scholar
  43. 43.
    Kahn, C.R. The syndromes of insulin resistance and acanthosis nigricans: insulin receptor disorders in man. N Engl J Med 1976; 294, 736–745.Google Scholar
  44. 44.
    Stuart, C.A., Smith, M.M., Gilkison, C.R., Shaheb, S., and Stahn, R.M. Acanthosis Nigricans among native americans: an indicator of high diabetes risk. Am J Public Health 1994; 84, 1839–1842.PubMedCrossRefGoogle Scholar
  45. 45.
    Cruz, P.D. Excess insulin binding to insulin-like growth factor receptors: Proposed mechanism for acanthosis nigricans. J Invest Dermatol 1992; 98 (suppl), 82S–85S.PubMedCrossRefGoogle Scholar
  46. 46.
    Rosenberg, A.M., Haworth, J.C., Degroot, G.W., Trevenen, C.L., and Rechler, M.M. A case if leprechaunism with severe hyperinsulinemia. Am J Dis Child 1980; 134, 170–175.PubMedGoogle Scholar
  47. 47.
    Lawrence, R.D. Lipodystrophy and hepatosplenomegaly with diabetes, lipaemia, and other metabolic disturbances. A case throwing new light on the action of insulin. Lancet 1946; 1, 724–731.PubMedCrossRefGoogle Scholar
  48. 48.
    Hogan, P.A. “Cutaneous manifestations of endocrine diseases”. In Textbook of Pediatric Dermatology, Harper, J., Oranje, A., Prose, N., eds. Maiden, MA: Blackwell Science, Inc., 2000.Google Scholar
  49. 49.
    Torigoe, K., Numata, O., Yazaki, S., Hasegawa, S., Boku, N., Hiura, M., Ino, H., and Matsunaga, M. Sympathetic skin response in diabetic children: Do diabetic children have diabetic neuropathy? Pediatrics international 1999; 41, 631–636.PubMedCrossRefGoogle Scholar
  50. 50.
    Palcy, R.G., and Turnbridge, R.E. Dermal reaction in insulin therapy. Diabetes 1952; 1, 22–27.Google Scholar
  51. 51.
    Kahn, C.R., and Rosenthal, A.S. Immunologic reactions to insulin, insulin allergy, insulin resistance and the autoimmune insulin syndrome. Diabetes Care 1979; 2, 283–295.PubMedGoogle Scholar
  52. 52.
    Patterson, R„ Mellies, C.J., and Roberts, M. Immunologic reactions against insulin. II. IgE anti-insulin, insulin allergy and combined IgE and IgG immunologic insulin resistance. J Immunol 1973; 110, 1135–1145.Google Scholar
  53. 53.
    Johnson, D.A., and Parlette, H.Z. Insulin-induced hypertrophic lipodystrophy. Cutis 1983; 32, 273–275.PubMedGoogle Scholar
  54. 54.
    Reeves, W.G., Allen, B.R., and Tattersall, R.B. Insulin induced lipoatrophy: evidence for an immune pathogenesis. Br Med J 1980; 280, 1500–1503.PubMedCrossRefGoogle Scholar
  55. 55.
    Wright, A.D., Walsh, C.H., Fitzgerald, M.G., et al. Very pure porcine insulin in clinical practice. BMJ 1979; 1, 25–27.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2003

Authors and Affiliations

  • Pearl C. Kwong
    • 1
  1. 1.Department of Dermatology Nemours Children’s ClinicJacksonvilleUSA

Personalised recommendations